APA (7th ed.) Citation

B, H., F, D., Y, H., F, S., & Y, R. (2023). Re: Real world clinical outcome of cefiderocol for treatment of multidrug-resistant non-fermenting gram-negative bacilli infections: author's response. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 29(6), 812. https://doi.org/10.1016/j.cmi.2023.02.019

Chicago Style (17th ed.) Citation

B, Hoellinger, Danion F, Hansmann Y, Schramm F, and Ruch Y. "Re: Real World Clinical Outcome of Cefiderocol for Treatment of Multidrug-resistant Non-fermenting Gram-negative Bacilli Infections: Author's Response." Clinical Microbiology and Infection : The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 29, no. 6 (2023): 812. https://doi.org/10.1016/j.cmi.2023.02.019.

MLA (9th ed.) Citation

B, Hoellinger, et al. "Re: Real World Clinical Outcome of Cefiderocol for Treatment of Multidrug-resistant Non-fermenting Gram-negative Bacilli Infections: Author's Response." Clinical Microbiology and Infection : The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, vol. 29, no. 6, 2023, p. 812, https://doi.org/10.1016/j.cmi.2023.02.019.